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Preservation of renal function in experimental glomerulonephri.
tis. To evaluate the protective effect of dietary phosphorus re-
striction in an immunologic model of experimental renal disease,
we randomized 24 Sprague-Dawley rats with established nephro-
toxic serum nephntis into two groups. Group A animals (N = 13)
were fed a diet with a normal phosphorus content (0.5% phos-
phorus), and group B animals (N = 11) received an identical diet
low in phosphorus (0.04% phosphorus). Over the ensuing 133
days, group A rats developed progressive renal failure and had a
mean serum creatinine concentration of 3.0 0.5 mgldl at the
time of death or completion of the study. In contrast, group B
animals maintained near normal renal function and had a final
mean serum creatinine concentration of 0.93 + 0.2 mg/dl (P <
0.001). Survival was markedly improved in group B animals (P <
0.001). Histologic damage was diminished greatly in group B ani-
mals by both light and electron microscopy; immunofluores-
cence was positive in all animals. Group A animals had increased
kidney calcium concentration (30 6 mmoles/kg) when com-
pared to group B animals (18 I mmoles/kg) and animals with
normal kidneys (13 I nmoles/kg, P <0.001). Conclusion.
Dietary restriction of phosphorus retards functional deteriora-
tion and reduces histologic damage in experimental immunologic
renal disease. The mechanism for this protective effect has not
been elucidated.
Protection de Ia fonction rénale au cours de Ia glomérulonéph-
rite experimentale. Pour évaluer l'effet protecteur de la restric-
tion alimentaire de phosphore dans un modèle immunologique
d'atteinte rénale expérimentale, 24 rats Sprague-Dawley atteints
de néphrite sérique ont été répartis au hasard dans deux
groupes. Les animaux du groupe A (N = 13) ont recu une au-
mentation a contenu de phosphore normal (0,5% phosphore)
alors que ceux du groupe B (N = 11) ont recu une alimentation
semblable mais pauvre en phosphore (0,04% phosphore). Au
cours des 133 jours ultérieurs, les animaux du groupe A ont
développé une insuffisance rénale progressive avec une créati-
nine sérique moyenne de 3,0 0,5 mgldl au moment de leur mort
ou de Ia fin de l'étude. Les animaux du groupe B, au contraire
ont conserve une fonction rénale proche de Ia normale avec une
créatinine de 0,93 0,2 mg/dl (P <0,001) a Ia fin de l'étude. La
survie a été plus importante chez les animaux du groupe B (P <
0,001). Les lesions histologiques étaient moms importantes, en
microscopie photonique et électronique, chez les animaux du
groupe B alors que l'immunofluorescence était positive chez
tous les animaux. Les animaux du groupe A avaient une augmen-
tation de Ia concentration rénale de calcium (30 6 mmoles/kg)
par comparaison aux animaux du groupe B (18 1 mmoles/kg)
ou a des animaux normaux (13 I mmoles/kg, P <0,001).
Conclusion. La restriction alimentaire de phosphore retarde la
dCtérioration fonctionnelle et réduit les lesions histologiques au
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cours d'une maladie rénale expérimentale immunologique. Le
mécanisme de cet effet protecteur n'a pas été élucidé.
Restriction of dietary phosphorus prevents dete-
rioration of renal function in the remnant kidney
model of chronic renal failure in the rat [1]. This
protective effect of phosphorus restriction presum-
ably is mediated by prevention of renal calcifica-
tion, as suggested by lowered kidney calcium and
phosphorus content in phosphate-depleted animals.
Because construction of the remnant kidney is an
aggressive procedure involving cauterization of the
entire remnant cortex, much of the renal calcifica-
tion could result from dystrophic "scar" deposition
of calcium and phosphorus in the cauterized tissue,
rather than from direct parenchymal calcification.
Thus, amelioration of scar calcification might in
some way preserve renal function without affecting
any ongoing distructive parenchymal process.
To avoid such problems and to evaluate a mode
of chronic renal failure more akin to human disease,
we have studied the effect of dietary restriction of
phosphorus on the course of nephrotoxic serum
nephritis [2—4].
Methods
Nephrotoxic serum samples were obtained from
rabbits repeatedly immunized with purified rat gb-
merular basement membrane prepared according to
the method of Greenspon and Krakower [5]. Each
rabbit was injected monthly with 10 mg of purified
rat glomerular basement membrane in complete
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Freund's adjuvant. Adequacy and potency of anti-
sera was assessed by the finding of strongly positive
linear staining of glomerular capillary loops of nor-
mal rat kidney slices with double-layer immuno-
fluorescence. The nephrotoxic serum samples were
prepared for injection by heating at 56° C for 30
mm, followed by adsorption with normal rat red
blood cells for 60 mm.
Nephrotoxic serum nephritis was induced in 24
male Sprague-Dawley rats, each weighing between
200 and 225 g. All animals had been previously uni-
nephrectomized. Nephrotoxic serum, as prepared
above, was injected slowly into rats via per-
cutaneous puncture of a tail vein. Each animal re-
ceived 2.0 ml of nephrotoxic serum. All animals
were preimmunized 4 to 5 days prior to receiving
nephrotoxic sera with normal rabbit globulin (10
mg) injected i.m. and s.c. in incomplete Freund's
acjuvant. Immediately after injection of nephrotox-
ic sera, all animals were placed into individual
metabolic cages, and 24-hour urine collections were
performed.
Following induction of nephritis, all animals were
begun on a diet containing 0.5% phosphorus (regu-
lar phosphorus diet). This diet is a commercially
available low-phosphorus diet (0.04% phosphorus)
(ICN Pharmaceuticals, Inc., Cleveland, Ohio) to
which was added phosphorus (4 parts of sodium
phosphate to 1 part of sodium biphosphate) to bring
the total dietary phosphate content to 0.5%. After
30 days, the animals were randomized into two
groups. Group A (13 rats) was continued on a regu-
lar phosphorus diet. Group B (11 rats) was
changed to the identical diet without added phos-
phorus, resulting in a phosphorus content of 0.04%
phosphorus (low-phosphorus diet). Sodium chlo-
ride was added to the low-phosphorus diet so that
both diets contained a similar sodium content
(1.0%). Although not pair-fed, animals in both
groups were fed comparable amounts of food, with
group B actually eating more diet because food con-
sumption markedly decreased in group A animals
with the onset of uremia.
Blood was obtained for analysis I week after in-
jection of nephrotoxic serum and every 2 weeks
thereafter. The animals were placed in individual
metabolic cages to determine urinary protein excre-
tion just after injection of nephrotoxic serum, at 4
weeks just prior to randomization, and again at 8
weeks. The study period was 133 days, at which
time all surviving animals were killed to obtain tis-
sue for histologic study and determination of kidney
mineral content.
Serum samples were analyzed in a Technicon II
autoanalyzer for urea nitrogen [6], creatinine [7],
and phosphorus [8]. Calcium was measured with a
Perkin Elmer model-370 atomic absorption spectro-
photometer. Tissue calcium and phosphorus in kid-
neys recovered at the time of sacrifice were mea-
sured by previously reported techniques [9]. Deter-
mination of urinary protein was performed by the
modified Lowry method [10]. Histologic examina-
tion included light microscopy, immunofluores-
cence, and electron microscopy of representative
sections of both group A and group B animals. All
values are reported as mean SEM. Statistical corn-
pansons were made with the Student t test except
where otherwise noted.
Results
Calcium and phosphorus. Serum calcium and
phosphorus and urinary calcium and phosphorus
excretion 4 weeks after randomization are shown in
Figs. 1 and 2. At this time, the degree of phosphorus
restriction is reflected in a mean serum phosphorus
of 3.0 0.2 mgldl as compared to 7.8 0.6 mg/dl in
the nonrestricted animals (P < 0.001). The degree
of phosphorus depletion in group B animals is re-
flected by the markedly low urinary phosphorus ex-
cretion of 0.1 0.01 mg/24 hr vs. 6.7 3.5 mg124
hr in group A animals (P 0.001). The hypercal-
ciuria of phosphorus depletion was evident in group
B animals as well (22.1 14.0 vs. 2.9 1.3 mg/24
hr, P <0.001).
There was no significant difference in weights be-
tween the two groups of animals. Animal weights in
group A and B animals were 286 11 and 292 14 g(P = NS) just prior to randomization, 268 19 and
257 14 g (P = NS) at 13 weeks when differences in
renal function in the two groups had reached signifi-
cance,and239 19and236± 18g(P= NS)atthe
time of death or completion of the study.
Protein excretion. Urinary protein excretion was
measured immediately after injection of nephrotox-
ic serum, at 4 weeks just prior to randomization,
and again at 8 weeks (Fig. 3). Protein excretion was
markedly elevated in both groups at each point in
time. There was no significant difference in protein
excretion between groups A and B at any time.
Renal function and survival. Figure 4 depicts
mean serum creatinine, for each group of animals,
determined at 2-week intervals. Both groups dem-
onstrated transient acute rises in serum creatinine
within 2 weeks after injection of nephrotoxic serum.
By the time of randomization, all animals had re-
turned to near normal levels of renal function. After
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Fig. 1. Plasma calcium and phosphorus values in normal-phos-
phorus and phosphorus-restricted animals 4 it'eeks after ran-
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domization, demonstrating significantly decreased plasma phos- Heterologous phase Autologous phase
phorus and increased plasma calcium in the phosphorus-restrict-
ed animals.
Fig. 3. Urinary protein excretion in normal-phosphorus ani,nals
and phosphorus-restri cted animals immediately after injection of
nephrotoxic seru,n, at 4 st'eeks just prior to randomization, and
at 8 weeks. Marked proteinuria is evident in both groups of ani-
mals during all collections. There is no significant difference in
. the amount of proteinuria between the two groups at any time.
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difference in survival was highly significant (P <
0.001, x2) (Fig. 5)•
Histology. Light microscopy, immunofluores-
.1..
20 P<O.O01 P<0.001
io. iT0.2$ 4 '
Restricted P Normal P Restricted P Normal P D
Calcium Phosphorus
cence, and electron microscopy were performed on
representative tissue from both groups of animals.
On light microscopy, group A animals had severe
glomerular and tubulointerstitial damage (Fig. 6).
The glomeruli were swollen and exhibited marked
.diffuse endocapillary and extracapillary prolifera-
Fig. 2. Urinary calcium and phosphorus excretion in nor,nal- tion with virtually 100% crescent formation. There
phosphorus and phosphorus-restricted animals 4 t'eeks after
randomization, demonstrating significantly decreased phos-
phorus excretion and increased calciwn excretion in the phos-
phorus-restricted animals,
was generalized insterstitial scarring with tubular
dilitation and dropout, as well as marked interstitial
inflammatory infiltrate. In contrast, group B animals
exhibited only mild changes (Fig. 7). Although the
glomeruli demonstrated some endocapillary prolif-
eration, this change was mild, and crescent forma-
randomization, group A animals exhibited progres- tion was unusual. In addition, interstitial changes
sive renal functional impairment, but group B ani- were subtle, and the tubules were intact. There was
mals maintained near normal renal function. By the little or no interstitial inammatory infiltrate. Vessels
11th week of the study, this difference in serum were normal in both groups of animals. Immunofluo-
creatinine concentration had reached statistical sig- rescence was identical in both groups of animals. As
nificance, and this difference became increasingly can be seen in Fig. 8, taken from a phospho-
significant over the duration of the study. rus-restricted animal, there was intense linear stain-
Survival was significantly less in group A ani- ing of the glomerular capillary loops by anti-rat
mals. Only I of 13 group A animals was alive at the IgG. No granular staining was noted, and all fluo-
completion of the study, but 8 of 11 group B animals rescence was limited to glomeruli. Staining was un-
survived. All deaths in group A animals were due to iformly absent for 1gM, IgA, and albumin. C3 was
renal failure, with a mean serum creatinine concen- only occasionally noted and when present was
tration in this group being 3.0 0.5 mg/dl at the usually in small amounts at the periphery of the
time of death. Of the 3 animals in group B who died, glomerular tuft. Fibrinogen was present in associa-
only 2 died with an elevated serum creatinine. This tion with crescents in both groups of animals.
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Fig. 4. Serum creatinine plotted vs. time in normal-phosphorus
and phosphorus-restricted animals. The normal-phosphorus ani-
mals manifest a triphasic disease (see text) with progressive
functional impairment. The phosphorus-restricted animals have
significantly lower serum creatinine at week 11 (P < 0.25). This
difference is accentuated during the remainder of the study pen-
ol (P < 0.001 by 21 weeks). NSN is nephrotoxic serum ne-
phritis.
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Fig. 5. Percent of animals surviving in both groups throughout
the study. At the conclusion of the study, only 1 animal was alive
in group A, whereas 8 of the 11 animals in group B were still
alive.
In group A animals, electron microscopy re-
vealed marked endothelial and mesangial cell prolif-
eration. Rare intramembranous deposits were
noted, but there were no subendothelial or sub-
epithelial deposits. Tubular cell architecture was
completely disrupted, with extensive mitochondrial
damage. Calcification was prominent in tubular epi-
thelial cells, tubular basement membrane, and par-
ticularly within disrupted mitochondria. Electron
microscopy of group B tissue showed only mild pro-
liferative changes without electron-dense deposits.
The tubular cells in these animals appeared normal,
and calcium deposits were not seen.
Kidney weight was significantly greater in group
A animals as compared to nonuremic phosphorus-
restricted animals, 3.5 0.3 vs. 2.0 0.1 g (P <
0.001).
Kidney mineral content. Kidney calcium and
phosphorus data are represented in Figs. 9 and 10.
Kidney calcium content was significantly greater in
group A animals (30 6.0 mmoles/kg) than it was in
either group B animals (18 1.0 mmoles/kg) or ani-
mals with normal kidneys (13 1.0 mmoles/kg) (P
< 0.001). An unexpected finding was a markedly
elevated phosphorus content in the phosphorus-re-
stricted animals. To be certain that this increase in
kidney phosphorus was not the result of dietary
phosphorus restriction, we determined the kidney
phosphorus content in control animals maintained
for 19 weeks on a low-phosphorus diet identical to
the diet fed to the experimental animals. As can be
seen in Fig. 10, kidney phosphorus content in non-
uremic phosphorus-restricted animals (405 15
mmoles/kg) was significantly higher than it was in
group A animals (300 13 mmoles/kg), animals
with normal kidneys (359 7 mmoles/kg), and low-
phosphorus control animals (350 3 mmoles/kg) (P
<0.02).
Discussion
Nephrotoxic serum nephritis is an experimental
model of glomerulonephritis thought to be analo-
gous to immunologic forms of human renal disease.
The course of disease in this model occurs as two
distinct pathogenetic phases [11—13]. The early, or
heterologous phase, is thought to result from gb-
merular damage secondary to deposition of rabbit
o—-.o Restricted-P NSN
•: Normal-P NSN
<.005 <.001
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Fig. 6. Light ,nicrograph of renal cortex from normal-phosphorus animal, demonstrating crescentic glo,nerulonephritis and severe
interstitial disease t'ith tubular dilatation and atrophy, scarring, and marked inflammatory cell infiltration. (Original magnification, X
100)
immunoglobulin on rat glomerular basement mem-
brane. The late, or autologous phase, occurs as a
result of rat-forming antibodies against the heterolo-
gous rabbit protein. The autologous phase can be
accentuated experimentally by preimmunization of
the animal with heterologous protein some days be-
fore injection of nephrotoxic serum [14]. In this
study, all animals received 10 mg of normal rabbit
globulin in incomplete Freund's adjuvant 5days pri-
or to induction of nephritis so as to "sensitize" the
animal to rabbit globulin and thus potentiate the au-
tologous phase of disease.
Functionally, these animals manifest a triphasic
disease. The first phase, corresponding to the heter-
ologous phase, is characterized by abrupt deteriora-
tion of renal function with marked proteinuria im-
mediately after injection of nephrotoxic serum.
Renal function returns to normal during the second
phase. The final phase of this disease begins at
about 12 weeks after injection of nephrotoxic serum
and is characterized by progressive functional dete-
rioration with death in renal failure over a 2- to 3-
month period. This corresponds to the autologous
phase of disease and was the course of our non-
restricted animals.
Restriction of dietary phosphorus appeared to
ameliorate the autologous phase of nephrotoxic
nephritis, so that group B animals did not have pro-
gressive functional impairment. Indeed, in these an-
imals renal function remained near normal over the
duration of the study, and survival in the phos-
phorus-restricted animals was improved markedly.
Histologic changes were mild in the phosphorus-
restricted animals, but the animals on a normal
phosphorus diet demonstrated severe glomerular
and interstitial damage. The phosphorus-restricted
animals thus did not develop the marked crescentic
glomerulonephritis or the inflammatory and fibrotic
interstitial disease so prominent in the animals on a
normal-phosphorus diet. That both groups of ani-
mals had significant active disease, however, is evi-
denced by strongly positive linear immuno-
fluorescence and high-grade proteinuria in all ani-
mals.
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Fig. 7. Light rnicrograph of renal tissue fro,n restrictive-phosphorus animals, illustrating modest proliferative glomerulonephritis ab-
sence of crescents, and intact tubules and interstiriu,n. (Original magnification, x 100)
In the remnant kidney model of chronic renal fail-
ure, dietary restriction of phosphorus was thought
to ameliorate the development of renal failure by
prevention of calcification. In that study, kidney
calcium content was markedly elevated in the non-
phosphorus-depleted rats (251 53 mmoleslkg) (P
<0.001). In this study of nephrotoxic serum nephri-
tis, tissue calcium content was also significantly in-
creased in nonrestricted animals (30 6 mmoles/
kg) as compared with animals on a phosphorus-re-
stricted diet (18 I mmoles/kg) and controls (13
1 mmoles/kg) (P < 0.001). The kidney calcium con-
tent in nonphospcus-restricted remnant kidney
animals is an orde o magnitude higher than that in
nonphosphorus-restricted nephrotoxic serum nephri-
tis animals, 251 53 vs. 30 6 mmoles/kg. This is
to be expected because much of the calcium in the
remnant kidney is dystrophic or scar calcification.
It should be emphasized, however, that, even
though much lower than in nonrestricted remnant
kidneys, kidney calcium content in the non-
restricted nephrotoxic serum nephritis animals is in-
creased over control and restricted animals. In ad-
dition, histochemical techniques have demon-
strated similar patterns of localization of calcium-
phosphorus deposits in parenchyma of end-stage
remnant kidneys and nephrotoxic serum nephritis
kidneys, that is, in renal tubular epithelial cells and
tubular basement membrane. Thus, parenchymal
calcification, with an associated inflammatory and
fibrotic response, could be an important patho-
genetic mechanism as a final common pathway of
renal damage in both models.
An unexpected finding was the presence of in-
creased kidney phosphorus concentration in the
phosphorus-restricted nephrotoxic serum nephritis
animals as compared with control animals on a nor-
mal or low-phosphorus diet. The phosphorus con-
tent in the kidneys of the nephrotoxic serum nephri-
tis animals maintained on a normal phosphorus in-
take was significantly reduced as compared to
controls. In view of the marked histologic damage
with severe nephron destruction and replacement
by scar tissue in nonrestricted animals, a decrease
in tissue phosphorus concentration would be ex-
pected. The increase in tissue phosphorus in phos-
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Fig. 8. Immunofluorescent study of renal tissue from a phosphorus-restricted ani,nals using rabbit and anti-rat IgG. Strongly positive
linear fluorescence is apparent.
phorus-restricted animals when compared with con-
trol animals on an identical low-phosphorus diet for
19 weeks suggests that phosphorus restriction itself
is not responsible for this phenomenon. Also, the
kidney phosphorus concentration has been found to
be increased in a few group A animals who died
early in the course of nephrotoxic serum nephritis
prior to developing extensive histologic damage.
We would therefore conclude that early in nephro-
toxic serum nephritis kidney phosphorus content is
increased; as animals develop progressive nephron
loss with collagen formation, tissue phosphorus
drops. With amelioration of disease progression and
maintenance of parenchymal integrity, tissue phos-
phorus content remains high. It may well be that
phosphorus plays a role in mediating the renal dis-
ease induced by nephrotoxic serum. The exact sig-
nificance of this increased kidney phosphorus con-
centration remains to be determined.
The most apparent reason for the protective ef-
fect of dietary phosphorus restriction is that it pre-
vents renal calcification. Phosphorus restriction
could prevent renal calcification by one of several
mechanisms. First, phosphorus restriction sup-
presses PTH levels and prevents secondary hyper-
parathyroidism in animals with chronic renal failure
[15]. PITH has previously been implicated in induc-
ing renal calcification. Baker et al found that in-
creasing calcium levels to 12 to 14 mgldl by the
administration of calcium salts did not result in
nephrocalcinosis, whereas a similar degree of
hypercalcemia produced by the administration of
parathyroid extract resulted in renal calcification
[16, 17]. In addition, the administration of smaller
doses of parathyroid extract, which did not produce
renal calcification in an intact animal, did so in a
uninephrectomized animal. The authors suggested
that the hypertrophied kidney for some unexplained
reason was particularly susceptible to the develop-
ment of PTH-induced calcification. Thus, the dis-
eased kidney might also have an increased suscepti-
bility to calcification. Furthermore, the pattern of
calcification resulting from the administration of
parathyroid extract is similar to that found in the
end-stage kidney in that calcium is initially depos-
ited in the tubular epithelial cells and tubular base-
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ment membrane. Additional evidence that PTH
may induce renal calcification by mechanisms other
than hypercalcemia are the findings of Schneider,
Reaven, and Graven demonstrating that the pattern
of calcification is different when calcification is in-
duced by parathyroid extract as compared to the
administration of calcium salts [18]. Whether para-
thyroidectomy prevents renal calcification and/or
functional deterioration in this and other models of
chronic renal failure will require direct examina-
tion.
A second mechanism by which dietary phos-
phorus restriction is protective could be by reduc-
ing calcium X phosphorus product and preventing
metastatic calcification. This appears unlikely be-
cause renal calcification has been shown to precede
calcification in other organ systems and occurs pri-
or to an increase in calcium x phosphorus product.
In addition, although calcification of renal tissue is
almost invariably in end-stage kidneys both from
humans and animal models, other soft tissue calcifi-
cation (aorta, heart, lung) in chronic uremia is quite
variable in regard to intensity and even occurrence
(Ibels et al, submitted for publication). To explain
this difference, it would have to be assumed that the
kidney is considerably more sensitive to the devel-
opment of metastatic calcification than other organs
are.
A third possibility is that phosphorus restriction
prevents a dystrophic form of calcification in a dis-
eased or damaged organ. This seems unlikely be-
cause calcification is found in tubular epithelial cells
and tubular basement membranes rather than in
scarred areas of the kidney as would be expected in
a dystrophic type of calcification. Also, it would ap-
pear likely that in dystrophic forms of calcification,
kidney calcium concentration should vary widely.
This is not the case.
With a reduction in nephron population, renal
handling of phosphorus could be altered in such a
way as to make phosphorus directly nephrotoxic;
phosphorus restriction would then be protective by
diminishing the phosphorus load per nephron. Be-
cause phosphorus restriction is protective in both
the remnant kidney model, where single nephron
GFR is increased [20], and nephrotoxic serum
nephritis, where single nephron GFR would be ex-
pected to be normal or decreased [21], the filtered
load of phosphorus would not appear to be an im-
portant factor modulating function.
Bank, Su, and Aynedjian have shown that, in re-
nal failure, changes in phosphorus transport are me-
diated by PTH [20]. Other investigators, however,
have not found PTH necessary for phosphorus
homeostasis in renal failure [22]. Certainly the
adaptive response to high-phosphorus intake in
nonuremic animals occurs in the absence of PTH
[23—25]. It thus seems possible that a similar adapt-
ive mechanism, whether or not mediated by PTH,
could occur as a result of progressive renal in-
sufficiency and be toxic to the kidneys. One would
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Fig. 9. Kidney calcium content in normal-phosphorus and re-
stricted-phosphorus nephrotoxic serum nephritis (NSN) animals,
and normal kidneys. There is a significantly greater calcium con-
tent in NSN normal-phosphorus animals as compared with phos-
phorus-restricted NSN animals and normal kidneys (P <0.001).
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Fig. 10. Kidney phosphorus content in restricted and non-
phosphorus-restricted nephrotoxic serum nephritis (NSN) ani-
,nals, normal kidneys, and normal animals maintained on a low-
phosphorus diet for /9 weeks (restricted-phosphorus controls).
Kidney phosphorus content is increased in the phosphorus-re-
stricted NSN animals as compared with nonphosphorus-restrict-
ed animals and both groups of controls (P <0.02).
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expect this potentially "maladaptive" response to
be suppressed by phosphorus restriction.
A final possible mechanism is that phosphorus re-
striction alters the immunological or inflammatory
process. This is suggested somewhat by the finding
that phosphorus restriction markedly diminished
the crescents and proliferative glomerular lesions of
nephrotoxic serum nephritis. Monocytic infiltration
in the glomeruli in the autologus phase of this dis-
ease has been shown to play an important role in
mediating glomerular injury [26, 27] and crescent
formation [28]. Because phosphorus restriction has
been shown to affect polymorphonuclear leukocyte
function adversely [29], it seems equally as possible
that phosphorus restriction altered the monocytic
response preventing glomerular damage. This in
turn would imply that renal parenchymal calcifica-
tion is a secondary event rather than the primary
cause of the progressive renal damage. A dis-
tinction should be made between phosphorus deple-
tion and phosphorus deprivation. In other species
of animals, the metabolic consequences of phos-
phorus depletion are usually not seen until the
serum phosphorus has fallen to less than 1 mg/dl
[29-3 1]. In the animals in this study, plasma phos-
phorus concentrations were consistently greater
than 1 mgldl. This would suggest if the rat is like
other species, that cellular function should not be
severely altered by this level of phosphorus depri-
vation. Before this issue can be answered, how-
ever, additional studies are needed to investigate
the effect of phosphorus restriction on the immune
process and monocytic function.
These studies provide no additional insight into
the mechanism by which phosphorus restriction
prevents functional deterioration in a diseased kid-
ney. In addition, prior to using dietary restriction of
phosphorus as therapy in human forms of chronic
renal disease, several important questions must be
answered: (a) when in the course of renal failure
is phosphorus restriction effective, (b) how much
restriction is required for this protective effect,
and (c) by what mechanism is this effect medi-
ated?
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